Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the prior v3.4.1 notice and the government-funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:52:34.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a government funding lapse notice and a site revision tag (v3.4.1, replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:18.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor UI/text updates: a new 'Show glossary' option, capitalization tweaks in QC-related labels ('Last Update Submitted that Met QC Criteria'), the wording 'No FEAR Act Data' changed to 'No FEAR Act data', and a new 'Revision: v3.4.0' tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:34:32.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The update shows a new revision label (v3.3.4) replacing the previous v3.3.3, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:46:37.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section with California and Florida sites. Removed separate California and Florida location blocks and the HHS Vulnerability Disclosure, and updated to revision v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T13:31:33.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Minor site revision tag updated from v3.3.1 to v3.3.2, with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:25:27.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.